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Acute pancreatitis is an inflammatory disease process
which may present with clinical manifestations ranging
from benign self-limited disease to overwhelming
sepsis. The ability to predict outcome would be helpful
in developing treatment plans, and possibly in stratifying
patients for clinical trials.addition to just what cytokines are elevated. Specifically,In a recent issue of Critical Care, Nieminen and col-
leagues [1] hypothesized that cytokine profiles might
help predict disease severity and progression in patients
presenting with acute pancreatitis. Acute pancreatitis is
an inflammatory disease whose clinical presentation ex-
hibits a broad spectrum of severity ranging from mild self-
limited disease to severe progressive disease with organ
dysfunction and often death. The Atlanta Classification
defines three grades of severity based on clinical criteria,
namely mild pancreatitis, moderately severe pancreatitis,
and severe pancreatitis [2]. Mild pancreatitis shows no evi-
dence of organ dysfunction and no local or systemic com-
plications; moderately severe pancreatitis exhibits local or
systemic complications with either no or transient organ
dysfunction; severe pancreatitis is characterized by persist-
ent single or multiorgan dysfunction. Whereas mild pan-
creatitis is relatively easy to sort out, the latter two entities
are somewhat difficult. Various approaches to making this
distinction have been investigated, including biochemical
markers such as C-reactive protein, calcium, and cre-
atinine; scoring systems such as Acute Physiology and
Chronic Health Evaluation II; and radiological findings
such as contrast-enhanced computerized tomography
scans.
Evaluation of cytokine levels as predictors of disease
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the development of severe acute pancreatitis. IL-6, IL-8,
and IL-10 were suggested as potential predictors [3]. In
the present study, however, the authors have broadened
the net of cytokines studied by using commercially avail-
able kits which can measure multiple cytokines (in this
case, 48 different cytokines). There are several interest-
ing and novel questions asked by the investigators in
they perform their measurements when the patient is
admitted to the hospital with the diagnosis, asking
whether the single data point correlates with severe pan-
creatitis. Second, they studied whether the cytokine pro-
file can predict the progression of organ dysfunction in
patients. This latter determination is performed in a
retrospective fashion, since one would have only deter-
mined the development of organ dysfunction during the
course of the hospital stay.
The study reports on a total of 163 patients, 25 of
whom (15%) had a diagnosis of severe pancreatitis. Of
this group, 11 had organ dysfunction on admission and
14 developed organ dysfunction within a week of admis-
sion. The major findings were that 14 out of 47 cytokines
were higher on admission in patients who developed severe
pancreatitis compared with those with moderately severe
or mild disease and that IL-6 and hepatocyte growth factor
(HGF) were independent predictors of severe acute pan-
creatitis. The positive likelihood ratio (+LR), a measure of
diagnostic accuracy, was in the 5 to 10 range for each of
these independently and in combination. A +LR in excess
of 10 is interpreted as being consistent with a high likeli-
hood of disease and therefore of use in clinical practice. It
is noteworthy that some parameters currently used to pre-
dict severity - C-reactive protein, calcium, and creatinine -
exhibited comparable +LR values. In the interesting group
of patients who progressed to severe pancreatitis (that is,
developed persistent organ dysfunction) during their hos-
pital stay, IL-8, HGF, and granulocyte colony-stimulating
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ate analysis. However, when the clinically optimal cutoff
levels determined for each of these in the larger studies
were used, the ability to predict was generally poor.
The authors are quite clear in stating that determin-
ation of the above-mentioned cytokines, either alone or
in combination, at the time of admission does not add
significantly to the prediction of clinical course in this
patient population. This is perhaps not a surprising con-
clusion. Pancreatitis is a complex and heterogeneous dis-
ease which evolves over time. In the present article,
subjects are included if they are admitted within 72 hours
of the onset of their symptoms. We know from prior
studies that IL-6 levels in pancreatitis can rise and fall
over this time frame and thus the single admission time
point may not be representative of the IL-6 response [4].
In the present article, the authors conclude that the discov-
ery and measurement of other markers might improve the
prediction of severe pancreatitis. Relevant to cytokine bio-
markers, a recent translational research study implicated a
role for soluble IL-6 receptor (sIL-6R) in mediating the
pro-inflammatory effect of IL-6 during pancreatitis through
a process called IL-6 trans-signaling, in which IL-6 com-
plexes with sIL-6R and can induce alternative cellular sig-
naling cascades [5]. The ratio of serum IL-6 to sIL-6R was
suggested to be useful in distinguishing mild pancreatitis
from severe pancreatitis with acute lung injury. Obviously,
these and other novel pathways are worthy of study.
Finally, one might suggest that there is no need for
studies such as those reported by Nieminen and col-
leagues, since there is no intervention which has been
shown to modify the progression or severity of pancrea-
titis. However, practically speaking, when patients arrive
with acute pancreatitis, it would be helpful to know
whether this will progress or resolve. If the former, then
closer observation in a monitored setting, consultation
with a clinical expert, or even transfer to a specialty in-
stitution might be considered. Furthermore, having the
ability to more accurately predict outcome would poten-
tially permit stratification of patients for inclusion in
clinical trials.
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